Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Rafaele Calamia

Physician Assistant Bryn Mawr, PA Physician Assistant

NPI 1134295173 CMS profile 10927196

101 S Bryn Mawr Ave, Suite 300A, Bryn Mawr, PA 19010

Open in the dashboard

General payments

$5,397

307 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rafaele Calamia of Bryn Mawr, PA is reported in the CMS Open Payments database as having received $5,397 across 307 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,346 87
2024 General $1,668 94
2023 General $1,379 79
2022 General $660 30
2021 General $343 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rafaele Calamia
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Rafaele Calamia were reported at $1,346. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Rafaele Calamia Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $343 $132 $37–$438 $132
2022 $660 $155 $48–$522 $149
2023 $1,379 $167 $52–$557 $160
2024 $1,668 $178 $55–$600 $164
2025 $1,346 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Janssen Biotech, Inc. $931 57 payments
  2. AbbVie, Inc. $897 75 payments
  3. Sun Pharmaceutical Industries Inc. $586 25 payments
  4. E.R. Squibb & Sons, L.L.C. $555 36 payments
  5. Genzyme Corporation $365 12 payments
  6. Amgen Inc. $322 21 payments
  7. UCB, Inc. $293 11 payments
  8. Incyte Corporation $287 15 payments
  9. Regeneron Healthcare Solutions, Inc. $217 9 payments
  10. Arcutis Biotherapeutics, Inc. $190 10 payments
  11. Other $753 36 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,212 304 payments
  2. Education $185 3 payments
Products named General payments · program years 2021–2025
  1. TREMFYA $979 59 payments
  2. DUPIXENT $566 17 payments
  3. SOTYKTU $549 35 payments
  4. SKYRIZI Immunology $447 35 payments
  5. ILUMYA $357 15 payments
  6. Otezla $322 21 payments
  7. OPZELURA $287 15 payments
  8. RINVOQ $254 14 payments
  9. Bimzelx $186 6 payments
  10. SKYRIZI Immunology $180 25 payments
  11. Other $1,391 73 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

260

Median for Physician Assistant: 241

Drug cost

$6,289

Median for Physician Assistant: $4,110

Branded share of claims

0%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clobetasol Propionate Generic 41 $1,738
Ketoconazole Generic 75 $1,270
Tacrolimus Generic 11 $1,029
Fluorouracil Generic 15 $855
Fluocinonide Generic 24 $620
Triamcinolone Acetonide Generic 39 $281
Finasteride Generic 22 $230
Cephalexin Generic 14 $190
Mupirocin Generic 19 $76

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$78,383

Of which drugs: $3,271

Medicare patients

409

Average age 73

Services billed

1,813

265 women, 144 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 65%
Arthritis 42%
Ischemic heart disease 25%
Diabetes 21%
Chronic kidney disease 21%
Depression 19%
Osteoporosis 17%
Atrial fibrillation 13%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 18 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $218
$218 — —
TREMFYA
  • Janssen Biotech, Inc. $200
$200 — —
SKYRIZI
  • AbbVie, Inc. $182
$182 — —
DUPIXENT
  • Regeneron Healthcare Solutions, Inc. $99
  • GENZYME CORPORATION $64
$162 — —
Zoryve
  • Arcutis Biotherapeutics, Inc. $137
$137 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 18 in the dashboard with a free account

Records

307 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record